![Eamonn Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Eamonn Connolly worked as the Head of the Research Department at BioGaia AB from 2010 to 2011.
He then served as the Chief Scientific Officer at Infant Bacterial Therapeutics AB from 2013 to 2021.
Dr. Connolly obtained an undergraduate degree from The University of Manchester and a doctorate degree from the University of Manchester Institute of Science & Technology.
Antiguos cargos conocidos de Eamonn Connolly.
| Empresas | Cargo | Fin |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Director Técnico/Científico/I+D | 01/01/2021 |
| BIOGAIA AB | Director Técnico/Científico/I+D | - |
Formación de Eamonn Connolly.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
16
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
BioGaia AB
 BioGaia AB Pharmaceuticals: OtherHealth Technology Develops health care products such as foods with healthy additives and provides pharmaceutical research services | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
 University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infant Bacterial Therapeutics AB
 Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
- Bolsa de valores
- Insiders
- Eamonn Connolly
